Sunder Biomedical Tech. Co., Ltd.(TW:4115)
NT$6.970.00 (0.00%)
TW:4115
Sunder Biomedical Tech. Co., Ltd. Revenue
NT$6.97
At close:0.00 (0.00%)
Sunder Biomedical Tech. Co., Ltd. (4115) Revenue
Sunder Biomedical Tech. Co., Ltd. Revenue
Sunder Biomedical Tech. Co., Ltd. had a revenue of 367.66M in the quarter ending Jun 30, 2026, with -0.68%. This bring the company's revenue in the last twelve months to 737.86M, Decreased 2.07%. In the fiscal year ending Dec 31, 2025, Sunder Biomedical Tech. Co., Ltd. had annual revenue of 753.45M with -1.74% growth.
- Revenue (ttm)
- 737.86M
- Revenue Growth
- -2.88%
- P/S Ratio
- 0.56
- Revenue/Employee
- TWD 2,177,604
- Employees
- 346
- Market Cap
- TWD 418.20M
Revenue Chart
Sunder Biomedical Tech. Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 753.45M | -13.38M | -1.74% |
| Dec 31, 2024 | 766.83M | -3.36M | -0.44% |
| Dec 31, 2023 | 770.19M | -283.37M | -26.90% |
| Dec 31, 2022 | 1.05B | -86.06M | -7.55% |
| Dec 31, 2021 | 1.14B | 228.97M | 25.14% |
| Dec 31, 2020 | 910.65M | 68.77M | 8.17% |
| Dec 31, 2019 | 841.88M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.